J&J's DePuy Synthes nets clearance for Velys spine surgery robot

Johnson & Johnson MedTech has secured an FDA 510(k) clearance for its first robotically guided platform for spine surgery and has slated its commercial launch for the first half of next year.

The DePuy Synthes division’s Velys Spine system is designed to offer what the company describes as active robotic assistance.